Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject in iron deficiency anemia after OPCAB/MIDCAB
NCT04898569Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Feb 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Yonsei University. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04898569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898569.